Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.
Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 17, 2000 | Funding Round | $19M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advent International | — | Funding Round |